Frank HALLEY

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation

SUBSTITUTED PYRAZOLOPYRIDINES, COMPOSITIONS CONTAINING THEM, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE

HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors

Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε

Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof

Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof

Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use

Substituted indoles, compositions containing them, method for the production thereof and their use

Pyrrolopyrimidines

Substituted indazoles, compositions containing the same, and the preparation and use thereof

Novel compounds and compositions as cathepsin inhibitors

Novel compounds and compositions as cathepsin inhibitors

Azaindoles for inhibiting aurora2 and other kinases

Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon